Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Clinical Outcome
5 results:

  • 1. Survival outcome in Early-Onset Metastatic colorectal cancer: A Multicenter-Matched Pair Analysis.
    Doleschal B; Niedersüß-Beke D; Kirchweger P; Petzer A; Thaler J; Rumpold H
    Oncology; 2024; 102(2):107-113. PubMed ID: 37699362
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancer.
    Arai H; Xiao Y; Loupakis F; Kawanishi N; Wang J; Battaglin F; Soni S; Zhang W; Mancao C; Salhia B; Mumenthaler SM; Weisenberger DJ; Liang G; Cremolini C; Falcone A; Millstein J; Lenz HJ
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33172883
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer.
    Likui W; Hong W; Shuwen Z
    J Gastrointest Surg; 2010 Jan; 14(1):74-81. PubMed ID: 19763701
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. DPD is a molecular determinant of capecitabine efficacy in colorectal cancer.
    Vallböhmer D; Yang DY; Kuramochi H; Shimizu D; Danenberg KD; Lindebjerg J; Nielsen JN; Jakobsen A; Danenberg PV
    Int J Oncol; 2007 Aug; 31(2):413-8. PubMed ID: 17611699
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Long-term survival after curative resection for carcinoma of the rectum.
    Fändrich F; Schröder DW; Saliveros E
    J Am Coll Surg; 1994 Mar; 178(3):271-6. PubMed ID: 8149020
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.